Malvern-based BioTelemetry ranks among the Top 10 for gains in its share price on Standard & Poor’s 600 small-cap stocks index over the last year, writes Joseph DiStefano for the Philadelphia Inquirer.
The wireless medical technology company checked in at No. 9, after doubling in price.
BioTelemetry, formerly known as CardioNet, provides cardiac monitoring services. It also offers original equipment manufacturing with a focus on cardiac monitoring devices and centralized core laboratory services.
In addition to its Chester County headquarters, BioTelemetry has locations throughout the U.S., the U.K., and Japan employing around 1,600 people.
The company has also helped boost its share price over the years with several acquisitions. These include the purchase of Virtual Scopics and Telcare in 2016 and LifeWatch AG last summer.
Read more about BioTelemetry in the Philadelphia Inquirer here.
[uam_ad id=”80503″]
.
[uam_ad id=”80502″]
